Literature DB >> 15937770

Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative.

Christian Laurent1, Henriette Meilo, Jean-Baptiste Guiard-Schmid, Yacouba Mapouré, Jeanne-Marie Noël, Madeleine M'Bangué, Ashu Joko, Willy Rozenbaum, Fritz Ntoné Ntoné, Eric Delaporte.   

Abstract

A review of the hospital charts for 788 patients treated in 19 public and private clinics in Cameroon showed that clinical follow-up visits, biologic follow-up visits, and drug supply were irregular and that many patients interrupted treatment. Virological and immunologic effectiveness of therapy was as expected in patients for whom results were available.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15937770     DOI： 10.1086/430712

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  19 in total

1.  Retention and loss to follow-up in antiretroviral treatment programmes in southeast Nigeria.

Authors:  C A Onoka; B S Uzochukwu; O E Onwujekwe; C Chukwuka; J Ilozumba; C Onyedum; E A Nwobi; C Onwasigwe
Journal:  Pathog Glob Health       Date:  2012-03       Impact factor: 2.894

Review 2.  TB and HIV in the Central African region: current knowledge and knowledge gaps.

Authors:  S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch
Journal:  Infection       Date:  2013-12-06       Impact factor: 3.553

3.  Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.

Authors:  Ouzama Nicholson; Fay DiCandilo; James Kublin; Xiao Sun; Erin Quirk; Michelle Miller; Glenda Gray; Jean Pape; Michael N Robertson; Devan V Mehrotra; Steven Self; Katherine Turner; Jorge Sanchez; Punnee Pitisuttithum; Ann Duerr; Sheri Dubey; Lisa Kierstead; Danilo Casimiro; Scott M Hammer For The Merck V/Hiv Vaccine Trials Network Study Team
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

4.  Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?

Authors:  Nina Veenstra; Alan Whiteside; David Lalloo; Andrew Gibbs
Journal:  Global Health       Date:  2010-03-31       Impact factor: 4.185

5.  Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique.

Authors:  Bryan E Shepherd; Meridith Blevins; Lara M E Vaz; Troy D Moon; Aaron M Kipp; Eurico José; Ferreira G Ferreira; Sten H Vermund
Journal:  Am J Epidemiol       Date:  2013-06-19       Impact factor: 4.897

Review 6.  Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review.

Authors:  James H McMahon; Julian H Elliott; Steven Y Hong; Silvia Bertagnolio; Michael R Jordan
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

7.  Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Authors:  Elena Losina; Hapsatou Touré; Lauren M Uhler; Xavier Anglaret; A David Paltiel; Eric Balestre; Rochelle P Walensky; Eugène Messou; Milton C Weinstein; François Dabis; Kenneth A Freedberg
Journal:  PLoS Med       Date:  2009-10-27       Impact factor: 11.069

8.  Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon.

Authors:  Mathieu Rougemont; Beat E Stoll; Nadia Elia; Peter Ngang
Journal:  AIDS Res Ther       Date:  2009-10-12       Impact factor: 2.250

9.  Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study.

Authors:  Inés Oliveira; Andreas Andersen; Alcino Furtado; Candida Medina; David da Silva; Zacarias J da Silva; Peter Aaby; Alex Lund Laursen; Christian Wejse; Jesper Eugen-Olsen
Journal:  BMJ Open       Date:  2012-11-14       Impact factor: 2.692

10.  Trends and determining factors associated with adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and analysis of the CAMPS trial.

Authors:  Lawrence Mbuagbaw; Lehana Thabane; Pierre Ongolo-Zogo; David Yondo; Stephen Noorduyn; Marek Smieja; Lisa Dolovich
Journal:  AIDS Res Ther       Date:  2012-12-19       Impact factor: 2.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.